Normal Human Fibroblasts Express Pattern Recognition Receptors for Fungal (1→3)-β-d-Glucans

ABSTRACT Fungal cell wall glucans nonspecifically stimulate various aspects of innate immunity. Glucans are thought to mediate their effects via interaction with membrane receptors on macrophages, neutrophils, and NK cells. There have been no reports of glucan receptors on nonimmune cells. We investigated the binding of a water-soluble glucan in primary cultures of normal human dermal fibroblasts (NHDF). Membranes from NHDF exhibited saturable binding with an apparent dissociation constant (KD) of 8.9 ± 1.9 μg of protein per ml and a maximum binding of 100 ± 8 resonance units. Competition studies demonstrated the presence of at least two glucan binding sites on NHDF. Glucan phosphate competed for all binding sites, with a KD of 5.6 μM (95% confidence interval [CI], 3.0 to 11 μM), while laminarin competed for 69% ± 6% of binding sites, with a KD of 3.7 μM (95% CI, 1.9 to 7.3 μM). Glucan (1 μg/ml) stimulated fibroblast NF-κB nuclear binding activity and interleukin 6 (IL-6) gene expression in a time-dependent manner. NF-κB was activated at 4, 8, and 12 h, while IL-6 mRNA levels were increased by 48% at 8 h. This is the first report of pattern recognition receptors for glucan on human fibroblasts and the first demonstration of glucan binding sites on cells other than leukocytes. It also provides the first evidence that glucans can directly modulate the functional activity of NHDF. These results provide new insights into the mechanisms by which the host recognizes and responds to fungal (1→3)-β-d-glucans and suggests that the response to glucans may not be confined to cells of the immune system.

[1]  J. Kalbfleisch,et al.  Ligand binding to the (1 --> 3)-beta-D-glucan receptor stimulates NFkappaB activation, but not apoptosis in U937 cells. , 1998, Biochemical and biophysical research communications.

[2]  N. Tatsumi,et al.  Evaluation of a new laboratory test measuring plasma (1-->3)-beta-D-glucan in the diagnosis of Candida deep mycosis: comparison with a serologic test. , 1999, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[3]  D. Williams,et al.  Effect of enhanced macrophage function on early wound healing. , 1988, Surgery.

[4]  P. Leanderson,et al.  (1→3)-β-d-Glucan stimulates nitric oxide generation and cytokine mRNA expression in macrophages. , 1998, Environmental toxicology and pharmacology.

[5]  David L. Williams,et al.  Receptor binding and internalization of a water-soluble (1-->3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. , 1996, Journal of immunology.

[6]  Yoshiko Nakamura,et al.  [The Clinical Significance of Plasma] , 1998, Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology.

[7]  G. C. van den Bos,et al.  SOLUBLE GLUCAN PROTECTS AGAINST ENDOTOXIN SHOCK IN THE RAT: THE ROLE OF THE SCAVENGER RECEPTOR , 1998, Shock.

[8]  S. Y. Lee,et al.  A lipopolysaccharide- and beta-1,3-glucan-binding protein from hemocytes of the freshwater crayfish Pacifastacus leniusculus. Purification, characterization, and cDNA cloning. , 2000, The Journal of biological chemistry.

[9]  V. Vetvicka,et al.  Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). , 1996, Journal of immunology.

[10]  S. Pero,et al.  Activation of a Rel‐A/CEBP‐β‐related transcription factor heteromer by PGG‐Glucan in a murine monocytic cell line , 2000, Journal of cellular biochemistry.

[11]  D. Williams,et al.  Effect of macrophage stimulation on collagen biosynthesis in the healing wound. , 1997, The American surgeon.

[12]  V. Vetvicka,et al.  Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18). , 1997, Journal of immunology.

[13]  K. Miyake,et al.  Toll-Like Receptors Confer Responsiveness to Lipopolysaccharide from Porphyromonas gingivalis in Human Gingival Fibroblasts , 2000, Infection and Immunity.

[14]  J. Kalbfleisch,et al.  Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D -glucan increases long-term survival in polymicrobial sepsis , 1999 .

[15]  J. Dodge,et al.  Structure/activity relationships , 1998 .

[16]  E. Nemoto,et al.  Cleavage of CD14 on Human Gingival Fibroblasts Cocultured with Activated Neutrophils Is Mediated by Human Leukocyte Elastase Resulting in Down-Regulation of Lipopolysaccharide-Induced IL-8 Production1 , 2000, The Journal of Immunology.

[17]  Charles A. Janeway,et al.  Innate immunity: Lipoproteins take their Toll on the host , 1999, Current Biology.

[18]  M. Ochiai,et al.  A pattern-recognition protein for beta-1,3-glucan. The binding domain and the cDNA cloning of beta-1,3-glucan recognition protein from the silkworm, Bombyx mori. , 2000, The Journal of biological chemistry.

[19]  M. Quinn,et al.  Modulation of Endotoxin- and Enterotoxin-Induced Cytokine Release by In Vivo Treatment with β-(1,6)-Branched β-(1,3)-Glucan , 1999, Infection and Immunity.

[20]  E. Jones,et al.  Comparison of the carbohydrate biological response modifiers Krestin, schizophyllan and glucan phosphate by aqueous size exclusion chromatography with in-line argon-ion multi-angle laser light scattering photometry and differential viscometry detectors. , 1995, Journal of chromatography. B, Biomedical applications.

[21]  V. Vetvicka,et al.  Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. , 1996, The Journal of clinical investigation.

[22]  P. Anderson,et al.  Evidence for involvement of beta-glucan-binding cell surface lectins in human natural killer cell function. , 1994, Cellular immunology.

[23]  S. Pero,et al.  PGG‐Glucan activates NF‐κB‐like and NF‐IL‐6‐like transcription factor complexes in a murine monocytic cell line , 1997, Journal of leukocyte biology.

[24]  M. Ochiai,et al.  A Pattern-recognition Protein for β-1,3-Glucan , 2000, The Journal of Biological Chemistry.

[25]  P. Lachmann,et al.  Specificity of membrane complement receptor type three (CR3) for beta-glucans. , 1987, Complement.

[26]  James N. BeMiller,et al.  (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships , 1995 .

[27]  David L. Williams,et al.  IDENTIFICATION OF PHOSPHATE SUBSTITUTION SITES BY NMR SPECTROSCOPY IN A WATER-SOLUBLE PHOSPHORYLATED (13)-BETA -D-GLUCAN , 1998 .

[28]  B. Robertsen,et al.  Specificity of a β-glucan receptor on macrophages from Atlantic salmon (Salmo salar L.) , 1994 .

[29]  C. Janeway,et al.  An ancient system of host defense. , 1998, Current opinion in immunology.

[30]  L. Ryan,et al.  The cytokine stimulating activity of (1-->3)-beta-D-glucans is dependent on the triple helix conformation. , 2000, Carbohydrate research.

[31]  E. Jones,et al.  NMR spectral analysis of a water-insoluble (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1994, Carbohydrate research.

[32]  E. Jones,et al.  A method for the solubilization of a (1----3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1991, Carbohydrate research.

[33]  T. Tani,et al.  Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[34]  J. J. Crowley,et al.  PGG-glucan, a soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid beta-(1,3)-glucan receptor. , 1999, Immunopharmacology.

[35]  C. Janeway,et al.  Self-defense: the fruit fly style. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Adachi,et al.  Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1-->3)-beta-D-glucan preparation, sonifilan. , 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[37]  B. Stone,et al.  Chemistry and Biology of (1→3)-β-Glucans , 1992 .

[38]  D. Williams,et al.  The beneficial effect of enhanced macrophage function on the healing of bowel anastomoses. , 1996, The American surgeon.

[39]  K. Lemerise,et al.  Activation of rat macrophages by Betafectin PGG‐glucan requires cross‐linking of membrane receptors distinct from complement receptor three (CR3) , 1998, Journal of leukocyte biology.

[40]  Y. Adachi,et al.  Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. , 1995, Biological & pharmaceutical bulletin.

[41]  M. Dushkin,et al.  Carboxymethylated beta‐1,3‐glucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages In Vitro and modulates their plasma clearance In Vivo , 1996, Cell biochemistry and function.

[42]  J. Kalbfleisch,et al.  Ligand Binding to the (1 → 3)-β-D-Glucan Receptor Stimulates NFκB Activation, but Not Apoptosis in U937 Cells , 1998 .

[43]  S. Akira,et al.  CD11b/CD18 Acts in Concert with CD14 and Toll-Like Receptor (TLR) 4 to Elicit Full Lipopolysaccharide and Taxol-Inducible Gene Expression1 2 3 , 2001, The Journal of Immunology.

[44]  P. Wang,et al.  Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. , 2000, Biochemical and biophysical research communications.

[45]  J. J. Crowley,et al.  PGG-Glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: Evidence for a glycosphingolipid β-(1,3)-glucan receptor , 1999 .

[46]  C. Janeway,et al.  Lipoproteins take their toll on the host. , 1999, Current biology : CB.

[47]  M. Yamauchi,et al.  Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. , 1999, The American journal of physiology.

[48]  D. Williams,et al.  Lipid content of microparticulate (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae. , 1994, Microbios.

[49]  R. Arakaki,et al.  Lipoteichoic Acid Acts as an Antagonist and an Agonist of Lipopolysaccharide on Human Gingival Fibroblasts and Monocytes in a CD14-Dependent Manner , 1999, Infection and Immunity.

[50]  J. Kalbfleisch,et al.  inhibition Of Lps-induced Nfκb Activation By A Glucan Ligand Involves Down-regulation Of Ikkβ Kinase Activity And Altered Phosphorylation And Degradation Of Iκbα , 2000 .

[51]  T. T. Stevenson,et al.  A Novel Carbohydrate-Glycosphingolipid Interaction between a β-(1–3)-Glucan Immunomodulator, PGG-glucan, and Lactosylceramide of Human Leukocytes* , 1998, The Journal of Biological Chemistry.

[52]  E. Klein,et al.  The function of human NK cells is enhanced by β‐glucan, a ligand of CR3 (CD11b/CD18) , 1991, European journal of immunology.

[53]  V. Vetvicka,et al.  CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions , 1993, Clinical and experimental immunology.

[54]  H. Ensley,et al.  Development, physicochemical characterization and preclinical efficacy evaluation of a water soluble glucan sulfate derived from Saccharomyces cerevisiae. , 1991, Immunopharmacology.

[55]  J. Kalbfleisch,et al.  The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line. , 2000, Glycobiology.

[56]  Quan P. Ly,et al.  Nonviable Staphylococcus aureus and its peptidoglycan stimulate macrophage recruitment, angiogenesis, fibroplasia, and collagen accumulation in wounded rats , 1998, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.